KLA Corporation Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements

Fair Value Measurements

12 Months Ended

Jun. 30, 2014

FAIR VALUE MEASUREMENTS

The Company’s financial assets and liabilities are measured and recorded at fair value, except for equity investments in privately-held companies. These equity investments are generally accounted for under the cost method of accounting and are periodically assessed for other-than-temporary impairment when an event or circumstance indicates that an other-than-temporary decline in value may have occurred. The Company’s non-financial assets, such as goodwill, intangible assets, and land, property and equipment, are recorded at cost and are assessed for impairment when an event or circumstance indicates that an other-than-temporary decline in value may have occurred.

Fair Value of Financial Instruments. KLA-Tencor has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions and/or estimation methodologies could have a significant effect on the estimated fair value amounts. The fair value of the Company's cash equivalents, accounts receivable, accounts payable and other current liabilities approximate their carrying amounts due to the relatively short maturity of these items.

Fair Value Hierarchy. The authoritative guidance for fair value measurements establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below:



1级		Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.

Level 2		估值报价基于类似美国卫生工程师协会(asse)ts or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.

Level 3		Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

All of the Company’s financial instruments were classified within Level 1 or Level 2 of the fair value hierarchy as of June 30, 2014 , because they were valued using quoted market prices, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency. As of June 30, 2014 , the types of instruments valued based on quoted market prices in active markets included money market funds and certain U.S. Government agency securities, U.S. Treasury securities and sovereign securities. Such instruments are generally classified within Level 1 of the fair value hierarchy.

As of June 30, 2014 , the types of instruments valued based on other observable inputs included corporate debt securities, municipal securities and certain U.S. Government agency securities, U.S. Treasury securities and sovereign securities. The market inputs used to value these instruments generally consist of market yields, reported trades and broker/dealer quotes. Such instruments are generally classified within Level 2 of the fair value hierarchy.

The principal market in which the Company executes its foreign currency contracts is the institutional market in an over-the-counter environment with a relatively high level of price transparency. The market participants usually are large commercial banks. The Company's foreign currency contracts’ valuation inputs are based on quoted prices and quoted pricing intervals from public data sources and do not involve management judgment. These contracts are typically classified within Level 2 of the fair value hierarchy.

Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis as of the date indicated below were presented on the Company's Consolidated Balance Sheet as follows:



As of June 30, 2014 (In thousands)	Total			Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets
Cash equivalents:
U.S. Government agency securities	$	28,000		$	8,000	$	20,000
Municipal securities	2891年			—		2891年
Corporate debt securities	68,992			—		68,992
Money market and other	397,517			397,517		—
Marketable securities:
U.S. Treasury securities	384,400			365,401		18,999
U.S. Government agency securities	839,843			811,841		28,002
Municipal securities	93325年			—		93325年
Corporate debt securities	1,155,176			—		1,155,176
Sovereign securities	42,264			9,253		33,011
Total cash equivalents and marketable securities ⁽¹⁾	3,012,408			1,592,012		1,420,396
Other current assets:
Derivative assets	666			—		666
Other non-current assets:
Executive Deferred Savings Plan	159,995			105,311		54,684
Total financial assets ⁽¹⁾	$	3,173,069		$	1,697,323	$	1,475,746
Liabilities
Other current liabilities:
Derivative liabilities	$	(898	)	$	—	$	(898	)
Total financial liabilities	$	(898	)	$	—	$	(898	)

__________________

(1) Excludes cash of $106.7 million held in operating accounts and time deposits of $33.5 million as of June 30, 2014 .



As of June 30, 2013 (In thousands)	Total			Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets
Cash equivalents:
Corporate debt securities	$	3,800		$	—	$	3,800
Money market and other	817,608			817,608		—
Marketable securities:
U.S. Treasury securities	93,787			93,787		—
U.S. Government agency securities	598,031			598,031		—
Municipal securities	103,455			—		103,455
Corporate debt securities	1,099,525			—		1,099,525
Sovereign securities	33,805			13,559		20,246
Total cash equivalents and marketable securities ⁽¹⁾	2,750,011			1,522,985		1,227,026
Other current assets:
Derivative assets	4,016			—		4,016
Other non-current assets:
Executive Deferred Savings Plan	136,461			96,180		40,281
Total financial assets ⁽¹⁾	$	2,890,488		$	1,619,165	$	1,271,323
Liabilities
Other current liabilities:
Derivative liabilities	$	(2,173	)	$	—	$	(2,173	)
Total financial liabilities	$	(2,173	)	$	—	$	(2,173	)

__________________

(1) Excludes cash of $125.5 million held in operating accounts and time deposits of $43.4 million as of June 30, 2013 .

There were no transfers in and out of Level 1 and Level 2 fair value measurements during the fiscal year ended June 30, 2014 or 2013 . The Company did not have any assets or liabilities measured at fair value on a recurring basis within Level 3 fair value measurements as of June 30, 2014 or 2013 .

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details